300 related articles for article (PubMed ID: 15561738)
1. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
2. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
3. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
4. The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.
Hung HC; Lin CY; Liao YF; Hsu PC; Tsay GJ; Liu GY
Apoptosis; 2007 Mar; 12(3):475-87. PubMed ID: 17216583
[TBL] [Abstract][Full Text] [Related]
5. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
6. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody.
Ordóñez A; Yélamos J; Pedersen S; Miñano A; Conesa-Zamora P; Kristensen SR; Stender MT; Thorlacius-Ussing O; Martínez-Martínez I; Vicente V; Corral J
Thromb Haemost; 2010 Dec; 104(6):1143-9. PubMed ID: 20838745
[TBL] [Abstract][Full Text] [Related]
8. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.
Chang X; Han J
Mol Carcinog; 2006 Mar; 45(3):183-96. PubMed ID: 16355400
[TBL] [Abstract][Full Text] [Related]
9. The immune response to citrullinated antigens in autoimmune diseases.
Migliorini P; Pratesi F; Tommasi C; Anzilotti C
Autoimmun Rev; 2005 Nov; 4(8):561-4. PubMed ID: 16214096
[TBL] [Abstract][Full Text] [Related]
10. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
Suzuki A; Yamada R; Chang X; Tokuhiro S; Sawada T; Suzuki M; Nagasaki M; Nakayama-Hamada M; Kawaida R; Ono M; Ohtsuki M; Furukawa H; Yoshino S; Yukioka M; Tohma S; Matsubara T; Wakitani S; Teshima R; Nishioka Y; Sekine A; Iida A; Takahashi A; Tsunoda T; Nakamura Y; Yamamoto K
Nat Genet; 2003 Aug; 34(4):395-402. PubMed ID: 12833157
[TBL] [Abstract][Full Text] [Related]
11. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Yamamoto K
Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.
Matsuo K; Xiang Y; Nakamura H; Masuko K; Yudoh K; Noyori K; Nishioka K; Saito T; Kato T
Arthritis Res Ther; 2006; 8(6):R175. PubMed ID: 17125526
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
16. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
[TBL] [Abstract][Full Text] [Related]
17. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
Okumura N; Haneishi A; Terasawa F
Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
[TBL] [Abstract][Full Text] [Related]
18. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population.
Martinez A; Valdivia A; Pascual-Salcedo D; Lamas JR; Fernández-Arquero M; Balsa A; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
Rheumatology (Oxford); 2005 Oct; 44(10):1263-6. PubMed ID: 15998632
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis.
Yamada R
Autoimmun Rev; 2005 Apr; 4(4):201-6. PubMed ID: 15893712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
